Have a feature idea you'd love to see implemented?
Let us know!
SMTI Sanara MedTech Inc
Price (delayed)
$32.64
Market cap
$285.5M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.78
Enterprise value
$295.63M
With a focus on improving patient outcomes through evidence-based healing solutions and services, Sanara MedTech Inc. markets and distributes wound and skin care products and is seeking to offer wound
Highlights
SMTI's quick ratio has soared by 53% QoQ and by 8% YoY
Sanara MedTech's gross profit has increased by 28% YoY and by 8% QoQ
Sanara MedTech's net income has decreased by 34% QoQ but it has increased by 24% YoY
SMTI's EPS is down by 32% since the previous quarter but it is up by 26% year-on-year
Sanara MedTech's debt has increased by 39% QoQ
SMTI's equity is down by 3.7% since the previous quarter
Key stats
What are the main financial stats of SMTI
Market
Valuations
Earnings
Shares outstanding
8.75M
Market cap
$285.5M
Enterprise value
$295.63M
Price to earnings (P/E)
N/A
Price to book (P/B)
6.75
Price to sales (P/S)
3.82
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.08
Revenue
$72.41M
EBIT
-$5.18M
EBITDA
-$473,819
Free cash flow
-$3.14M
Per share
Balance sheet
Liquidity
EPS
-$0.78
Free cash flow per share
-$0.37
Book value per share
$4.84
Revenue per share
$8.55
TBVPS
$3.17
Total assets
$73.38M
Total liabilities
$31.98M
Debt
$16.28M
Equity
$41.71M
Working capital
$9.25M
Debt to equity
0.39
Current ratio
1.8
Quick ratio
1.45
Net debt/EBITDA
-21.37
Margins
Efficiency
Dividend
EBITDA margin
-0.7%
Gross margin
89.7%
Net margin
-9.1%
Operating margin
-11.4%
Return on assets
-8.9%
Return on equity
-15.1%
Return on invested capital
-25.5%
Return on capital employed
-8.4%
Return on sales
-7.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SMTI stock price
How has the Sanara MedTech stock price performed over time
Intraday
-3.35%
1 week
4.28%
1 month
7.05%
1 year
14.93%
YTD
-20.58%
QTD
7.94%
Financial performance
How have Sanara MedTech's revenue and profit performed over time
Revenue
$72.41M
Gross profit
$64.97M
Operating income
-$8.27M
Net income
-$6.57M
Gross margin
89.7%
Net margin
-9.1%
Sanara MedTech's net margin has increased by 37% YoY but it has decreased by 26% QoQ
Sanara MedTech's net income has decreased by 34% QoQ but it has increased by 24% YoY
The company's operating margin rose by 32% YoY
Sanara MedTech's gross profit has increased by 28% YoY and by 8% QoQ
Growth
What is Sanara MedTech's growth rate over time
Valuation
What is Sanara MedTech stock price valuation
P/E
N/A
P/B
6.75
P/S
3.82
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.08
SMTI's EPS is down by 32% since the previous quarter but it is up by 26% year-on-year
The price to book (P/B) is 39% lower than the 5-year quarterly average of 11.4 but 2.6% higher than the last 4 quarters average of 6.8
SMTI's equity is down by 3.7% since the previous quarter
The P/S is 50% lower than the 5-year quarterly average of 7.9 and 8% lower than the last 4 quarters average of 4.3
The company's revenue rose by 21% YoY and by 6% QoQ
Efficiency
How efficient is Sanara MedTech business performance
Sanara MedTech's return on invested capital has surged by 80% YoY but it has decreased by 2.4% QoQ
SMTI's return on sales has surged by 58% year-on-year but it is down by 18% since the previous quarter
The company's return on assets rose by 38% YoY but it fell by 27% QoQ
The company's return on equity fell by 34% QoQ but it rose by 25% YoY
Dividends
What is SMTI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SMTI.
Financial health
How did Sanara MedTech financials performed over time
The company's total assets is 129% higher than its total liabilities
The company's total liabilities has surged by 85% YoY and by 15% QoQ
SMTI's quick ratio has soared by 53% QoQ and by 8% YoY
Sanara MedTech's debt is 61% lower than its equity
SMTI's debt to equity is up by 44% since the previous quarter
Sanara MedTech's debt has increased by 39% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.